ACR Notice on Iodinated Contrast Media Access
Contrast supply is mostly stable, but high demand causes variability; ACR urges ordering only what’s needed.
Read moreThe Washington State Health Care Authority Health Technology Clinical Committee (HTCC) reviewed balloon angioplasty and stenting for lower extremity peripheral artery disease evidence Nov. 21. ACR® participated in the discussion along with the Society of Interventional Radiology, Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, and the Outpatient Endovascular and Interventional Society. ACR began monitoring this topic in August 2025.
HTCC issued draft findings and a coverage decision that are open for public comment until Dec. 16. The coverage determination is for Endovascular therapy for activity-limiting intermittent claudication and chronic limb-threatening ischemia as a covered benefit with conditions. ACR members who perform these procedures are encouraged to submit feedback. Email comments to shtap@hca.wa.gov.
Final findings and coverage decisions will be published in March. Meeting materials and presentations are on the HTCC website.
For more information or if you have questions, contact Alicia Blakey, ACR Principal Economic Policy Analyst.
ACR Notice on Iodinated Contrast Media Access
Contrast supply is mostly stable, but high demand causes variability; ACR urges ordering only what’s needed.
Read moreACR 2026: Evaluating AI Within Your Practice
AI panel highlighted tools for evaluating and integrating AI, stressing data-driven decisions, governance, and AI’s impact on radiology workflows.
Read moreACR 2026 Economics Forum Talks Efficiency, AI, Fair Payment
The forum covered CMS efficiency cuts, NSA dispute surge, policy impacts, and new AI economics efforts in radiology reimbursement.
Read more